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INTRODUCTION

S
tiffening of large arteries, mainly because of ageing, is a key feature of arteriosclerosis and cardiovascular disease [1] . Though carotid-femoral pulse wave velocity (cfPWV) is the most used and reliable method to measure aortic stiffness and is able to improve cardiovascular event prediction [2] , the evaluation of local arterial stiffness on the carotid arteries is of particular interest, as it can be directly determined without the need for any assumption from models of circulation [3] , it is easily accessed by ultrasound and it is evaluated in a classical site of atherosclerosis development. Moreover, the prognostic role of carotid mechanical properties has been demonstrated in patients with end-stage renal disease [4] as well as in the general population [5] . Despite hypertension being a major determinant of elastic properties of the carotid artery, the contribution of other cardiovascular risk factors in hypertensive patients [6] has been poorly investigated.
The development of target organ damage may represent a mechanism underlying the association of arterial stiffness and adverse cardiovascular events. This hypothesis is supported by a number of cross-sectional studies showing a significant association between cfPWV and subclinical coronary, peripheral arterial and cerebral target organ damage [7] , as well as renal damage [8] , whereas the association with left ventricular hypertrophy (LVH) is more controversial [9] . On the other side, the relationship between carotid stiffness and hypertensive target organ damage has been poorly studied [10, 11] . To our knowledge, the role of combined stiffening of carotid and aortic arterial districts on target organ damage and cardiovascular prognosis has never been explored. Multisite large artery stiffness might incrementally increase hemodynamic load on target organs, thus favoring the development of extensive damage. This aspect is of relevance as cardiovascular risk factors have a differential effect on carotid and aortic stiffness. Furthermore, reference values have recently become available for both parameters [12, 13] , but their reliability has never been tested against established intermediate endpoints.
The aims of the study were to evaluate the prevalence of increased aortic and carotid stiffness in a cohort of hypertensive patients, defined according to the Reference Values for Arterial Measurements Collaboration, as well as in comparison with a control group enrolled on purpose in our center; and to investigate whether the presence of increased carotid stiffness, cfPWV, or both are associated with hypertensive cardiac, vascular, and renal organ damage.
METHODS
Study population
A total of 314 essential hypertensive patients consecutively referring to the Hypertension Outpatient Clinic of the University Hospital of Pisa, Italy, for target organ damage evaluation, were enrolled. Inclusion criteria were diagnosis of essential hypertension defined on the basis of SBP at least 140 mmHg, DBP at least 90 mmHg, or use of antihypertensive drugs, according to current guidelines [14] . Exclusion criteria were known secondary forms of hypertension, end-stage renal disease, and any other major comorbidities, including active neoplasm, severe hepatic insufficiency and chronic heart failure, and any other disease reducing life expectancy at less than 1 year. A group of 110 healthy, normotensive individuals, comparable for age and sex, were also recruited as controls by advertising in the hospital. The institutional ethics committee approved the study and all patients provided written informed consent before entering the study.
Experimental protocol
Study participants were requested to refer to the Hypertension Outpatient Clinic in the morning after an overnight fasting for collection of medical history and anthropometric parameters as well as blood and urine samples, brachial blood pressure (BP) measurement, cardiac and vascular ultrasound, and arterial tonometry. Patients under pharmacological treatment were asked to assume their medications as usual on the day of the experimental session.
Experimental procedures
Cardiovascular risk factors estimation Medical history was collected for parental and personal history of cardiovascular disease and in first-degree relatives. Smoking status (current smoker/nonsmoker) was also recorded. In all patients, height, weight, and waist circumference were measured: obesity was defined when BMI more than 30 kg/m 2 , abdominal obesity when waist circumference was more than 102 cm for men and more than 88 cm for women. Patients were classified as having diabetes if fasting glucose was at least 7.0 mmol/l, or in the presence of glucose-lowering treatment. Dyslipidemia was defined as total cholesterol at least 5.0 mmol/l, or low density lipoprotein (LDL) cholesterol more than 3.0 mmol/l, high density lipoprotein (HDL) less than 1.2 mmol/l and less than 1.0 mmol/l for women and men, respectively, triglycerides more than 1.7 mmol/l, or current use of lipid-lowering drugs. Metabolic syndrome in hypertensive patients was defined as the concomitant presence of two or more risk factors among abdominal obesity, altered fasting plasma glucose (between 5.6 and 6.9 mmol/l) or diabetes, low HDL, or high triglycerides, as defined above. Glomerular filtration rate (eGFR) was estimated by the simplified Modification of Diet in Renal Disease equation [15] and renal function was considered impaired when eGFR was less than 60 ml/min per 1.73 m 2 . Microalbuminuria was defined according to European Society of Hypertension/European Society of Cardiology (ESH/ESC) 2013 Guidelines with albumin-to-creatinine ratio more than 30 mg/g [14] . Previous cardiovascular events were defined according to ESH/ESC 2013 Guidelines for hypertension management: myocardial infarction or coronary revascularization, stroke or transient ischemic events, heart failure, and symptomatic peripheral artery disease [14] .
Blood pressure measurement
Brachial BP was measured with the patient resting in supine position for at least 10 min under quiet environmental conditions, performing three measurements at 2-min intervals by an automatic oscillometric device (OMRON 705IT, HEM-759-E; Omron Corporation, Kyoto, Japan). BP was taken as the average of the last two measurements.
Applanation tonometry
Arterial tonometry was performed using standardized procedures [16] according to international guidelines [3] . cfPWV was assessed by SphygmoCor device (AtCor Medical, Sydney, New South Wales, Australia), recording waveforms sequentially at the femoral and carotid site. cfPWV was calculated as the ratio of the surface distance between the two recording sites -obtained subtracting carotid-suprasternal notch from femoral-suprasternal notch distance -and pulse transit time. Two consecutive measurements were recorded and averaged.
Carotid ultrasound
Common carotid artery scans (25 frames/s) were obtained by high-resolution ultrasound with a 10 MHz linear array transducer (MyLab25; ESAOTE, Florence, Italy) by a trained operator. Longitudinal scans were acquired from each common carotid artery (1 cm proximal to the carotid bulb in a region 1-cm wide and free of plaques) and automatically analyzed with Carotid Studio (Cardiovascular Suite, Quipu srl, Pisa, Italy), a well validated system based on contour tracking algorithm [17] . Arterial interfaces were automatically detected, with estimation of instantaneous mean diameter as the distance between far and near media-adventitia interfaces. Carotid measurements were validated for accuracy and precision against the gold standard approach by radiofrequency [17] . The following parameters were obtained: carotid distension (DD), that is the stroke change in diameter, calculated as the difference between the systolic and diastolic diameter values; carotid distensibility coefficient ¼ DA/(A Ã DP), where A represents the diastolic lumen area, evaluated from the diameter values (assuming the cross-section of the artery to be circular), DA represents the stroke change in lumen area, DP the local pulse pressure obtained by tonometry. Carotid stiffness was calculated according to the Moens-Korteweg equation [3] . In particular, carotid distensibility was converted into carotid stiffness by using the equation:
where r is the blood density. This formula allows carotid stiffness to be obtained as carotid stiffness ¼ (r Ã carotid distensibility)(À1/2), expressed in m/s, allowing a direct comparison with cfPWV. Finally, common carotid intima-media thickness (IMT) was simultaneously measured on the same image sequences of carotid stiffness, by the same computerized automatic system [17] . All parameters were then calculated as the average of the right and left common carotid values. For the definition of increased IMT, two different thresholds were considered: 0.9 mm, as indicated in the ESH/ESC Guidelines for the management of arterial hypertension [14] ; the 90th percentile of age and sex-specific reference intervals obtained in healthy individuals by echotracking techniques and calculated by the Reference Values for Arterial Measurements Collaboration [18] .
Echocardiography
A single trained operator performed echocardiography to measure left ventricular (LV) dimensions, wall thickness, and mass in accordance with current American Society of Echocardiography (ASE) guidelines [19] . LV mass was indexed to body surface area. Study participants with ejection fraction less than 40% were excluded from the analysis, because of the known confounding effect of systolic performance on cfPWV [20] . LVH was defined according to ESH/ESC 2013 Guidelines with a LV mass index more than 95 g/mq in women and more than 115 g/mq in men [14] .
Statistical analysis
All statistical analyses were performed using NCSS 8 (NCSS; Kaysville, Utah, USA). For normally distributed data, results were expressed as mean AE SD, whereas median value and 25-75% interquartile range was used for not normally distributed data. Differences in means between hypertensive and normotensive individuals were analyzed using analysis of variance (ANOVA) for normally distributed variables, or Kruskal-Wallis Z test for not normally distributed variables; differences in categorical variables were analyzed by x 2 test. Analysis of variance or covariance was used to compare cfPWV and carotid stiffness in the presence or absence of cardiovascular risk factors; for cfPWV, mean BP was considered as covariate. For the definition of increased cfPWV and carotid stiffness, two different thresholds were considered: first, they were considered increased when they were over the 90th percentile of the distribution obtained in the sample of healthy study participants enrolled in the present study; second, cfPWV and carotid stiffness values were also stratified according to age categories, as suggested by the Reference Values for Arterial Measurements Collaboration [12, 13] . For this purpose, brachial pulse pressure (PP) instead of carotid PP was used in the formula for carotid stiffness calculation [carotid stiffness (brach)].
Multiple logistic regression was performed to identify risk factors associated with an increased cfPWV and carotid stiffness. The hypertensive population was then divided in four groups according to the presence or absence of increased cfPWV and/or carotid stiffness and logistic regression analysis was used to establish the relationship between the presence of increased cfPWV and/or carotid stiffness and target organ damage. A multiple logistic regression model, adjusted for risk factors independently associated with increased cfPWV and carotid stiffness, was then built. Table 1 shows the clinical characteristics of the study population. The majority of hypertensive patients (68%) were on treatment with BP-lowering drugs (median number of drugs 2 [1] [2] [3] [4] ; 30% angiotensin-converting enzyme (ACE) inhibitors, 31% AT1 receptor blockers, 27% diuretics, 23% calcium channel blockers, 13% b-blockers, 4% others). Moreover, 18% of patients were treated with statins, 13% with antiplatelet drugs, and 20% with glucose-lowering drugs.
RESULTS
Clinical and vascular variables
Regarding vascular parameters (Table 2) , hypertensive patients had higher cfPWV than normotensive individuals. PP, carotid diameter, and carotid stiffness were significantly greater in hypertensive patients as compared with healthy study participants. Common carotid IMT was also significantly increased in the patients' group as compared with controls.
Prevalence of increased carotid stiffness and carotid-femoral pulse wave velocity
The 90th percentile of cfPWV and carotid stiffness in healthy individuals enrolled in the present study was 9.1 and 7.1 m/s, respectively (Fig. 1) . Using this cutoff, we found that 46.8% of the hypertensive population had increased cfPWV and 40.8% had increased carotid stiffness. The 90th percentile of carotid stiffness (brach) in healthy individuals enrolled in the present study was 8.0 m/s: according to this cutoff, 27.2% of hypertensive patients had increased carotid stiffness (brach).
When increased cfPWV and carotid stiffness (brach) were defined according to the age-specific 90th percentiles of the Reference Values for Arterial Measurements Collaboration, increased cfPWV was found in 34.0% and increased carotid stiffness (brach) in 9.6% of hypertensive patients.
Association of carotid stiffness and carotidfemoral pulse wave velocity with cardiovascular risk factors and treatments
Hypertensive patients with diabetes mellitus and metabolic syndrome had higher carotid stiffness than those without these risk factors (Table 3) . Carotid stiffness was significantly higher in women as compared with men but similar in patients treated or not with BP-lowering drugs (6.9 AE 1.5 versus 6.8 AE 1.3 m/s, P ¼ 0.43) or statins (7.1 AE 1.2 versus 6.9 AE 1.4 m/s, P ¼ 0.13).
Multiple logistic regression, including mean BP, mean carotid diameter, and heart rate (HR) as continuous variables, and age, sex, diabetes mellitus, metabolic syndrome, antihypertensive drugs, and statin use as discrete variables, showed that age [odds ratio (OR) 3.10 (confidence limits (CL) 95% 1. Hypertensive patients with previous cardiovascular events, family history of premature cardiovascular disease, diabetes mellitus, obesity, and metabolic syndrome had higher cfPWV as compared with patients without these risk factors (Table 3) . Furthermore, hypertensive patients on chronic treatment with BP-lowering drugs (9. Association of carotid stiffness and carotidfemoral pulse wave velocity with target organ damage in the hypertensive population
Within the hypertensive population (n ¼ 314), the prevalence of reduced eGFR (<60 ml/min) was 11.7% (out of 291 patients), albuminuria (albumin-to-creatinine ratio >30 mg/g) was 10.4% (out of 183 patients), and LVH (>95 g/mq in women; >115 g/mq in men) was 62.8% (out of 261 patients). The prevalence of increased common carotid IMT (>0.9 mm) was 14.0% (out of 314 patients), whereas, considering age and sex-stratified reference values for IMT, 147 individuals (47%) showed IMT greater than 90th percentile.
The hypertensive population was divided into four groups according to the presence or not of increased carotid and/or aortic stiffness according to 90th percentile of our healthy population: 38.8% presented neither carotid nor aortic stiffness (PWVÀCSÀ), 24.0% presented isolated increased cfPWV (PWVþCSÀ), 13.8% presented isolated increased carotid stiffness (PWVÀCSþ), and 23.4% presented both (PWVþCSþ). Microalbuminuria was equally prevalent in the four groups, whereas significant differences were found for the other kinds of target organ damage considered (Table 4a) . Increased carotid stiffness, with or without increased cfPWV (groups PWVÀCSþ and PWVþCSþ), was associated to an increased probability of having LVH in comparison with PWVÀCSÀ, both in the unadjusted model and in the model adjusted for age, mean BP, and diabetes. As sex-specific cutoffs were used for LVH BP, blood pressure; GFR, glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio. Ã P < 0.001 versus normotensive study participants. definition, sex was not included in the model. Conversely, reduced GFR was associated to increased cfPWV, in the presence or absence of increased carotid stiffness (groups PWVþCSÀ and PWVþCSþ), both in the adjusted and unadjusted model. PWVþCSþ was associated with an increased IMT (either defined according to the 0.9-mm cutoff or according to age-specific reference values), though significance was lost in the adjusted model (Table 4a) . When considering the 90th percentile of our healthy population, 60.3% of the studied population was classified in the PWVÀCS (brach)À group, 26.1% PWVþCS (brach)À, 12.5% PWVÀCS (brach)þ, and 1.0% PWVþCS (brach)þ.
LVH was more prevalent in patients with PWVÀCS (brach)þ in comparison with PWVÀCS (brach) À (OR 2.47, CL95% 1.21-5.07) when considering the 90th percentile of our healthy population. The association was present even after adjustment for mean BP and diabetes (OR 2.16, CL95% 1.04-4.49). For the latter analysis, we excluded the group PWVþCS(brach)þ because it was constituted of only four patients.
When the hypertensive population was divided in four groups according to Reference Values for Arterial Measurements Collaboration, 61.0% of the studied population was classified in the PWVÀCS (brach)À group, 28.5% PWVþCS(brach)À, 5.6% PWVÀCS(brach)þ, and 4.2% PWVþCS(brach)þ. No significant association between the presence/absence of carotid/aortic stiffness and any kind of target organ damage was found (Table 4b) .
DISCUSSION
In the present study, we investigated the association of carotid and aortic stiffness with target organ damage in a population of hypertensive patients referring to our center. The main finding of our study is that arterial stiffening of the two examined conductance arteries is differentially associated with target organ damage. Indeed, increased cfPWV was associated with renal target organ damage, whereas increased carotid stiffness was associated with cardiac organ damage. In contrast, the simultaneous presence of increased cfPWV and increased carotid stiffness did not result in an additive effect in terms of organ damage accrual. Furthermore, our results confirm that metabolic factors, such as obesity or diabetes, are the only risk factors showing an additive effect on arterial stiffening in addition to hypertension. Finally, our results indicated that prevalence of increased cfPWV and carotid stiffness, as well as association with target organ damage, varies considerably when a fixed cutoff obtained from a local control group or agespecific international reference values are used.
Association of carotid stiffness and carotidfemoral pulse wave velocity with target organ damage in the hypertensive population
The identification of a specific association between different measures of arterial stiffness and hypertensive target organ damage represents a novelty of the study. We found that increased cfPWV was specifically associated with renal target organ damage, whereas increased carotid stiffness correlated with cardiac organ damage. These observations have important clinical implication considering the role of hypertension on LVH and the fact that reduced eGFR is considered both a risk factor and target organ damage by ESH/ESC Hypertension Guidelines [14] . Although the crosssectional design of our study did not allow us to determine the causal effect of arterial stiffness on target organ damage, we recently found that higher cfPWV in newly diagnosed hypertensive patients at baseline resulted in a significant BP, blood pressure; CS, carotid stiffness; eGFR, estimated glomerular filtration rate; IMT, intima-media thickness; LVH, left ventricular hypertrophy; PWV, pulse wave velocity. a As sex and age are used for the calculation of eGFR, they were not included in the model. As sex-specific cutoffs were used for LVH definition, sex was not included in the model. As age-specific cutoffs were used for IMT definition, age was not included in the model.
GFR decline at 4 years of follow-up [21] . These data suggest that chronic kidney disease (CKD) might be an intermediate mechanism by which cfPWV induces cardiovascular events. A similar predictive value of cfPWV on GFR decline was observed in diabetic patients [22] , but not in the general population [23] , whereas conflicting data exist for CKD patients [24, 25] . Conversely, increased carotid stiffness is associated with cardiac organ damage, expressed as LVH. In agreement to our results, some evidence exists relating distensibility of large, elastic arteries, such as aortic arch and its main branches, evaluated by MRI and LVH [26, 27] . It is well known that a marked heterogeneity exists along the arterial tree in terms of molecular, cellular, and histological characteristics, leading to nonnegligible differences in local elasticity even among large elastic arteries, such as the common carotid artery and the thoracic aorta. On the other hand, as cfPWV is a measure of regional stiffness, including segments with heterogeneous wall composition, from central, elastic arterial segments, such as aorta and carotid artery, to muscular arteries, such as femoral artery [28] , the lack of relationship with LVH is not surprising and confirmed by current literature [9, 29] . Indeed, aortic characteristic impedance (Zc), the ratio between the pulsatile change in pressure and flow in the proximal aorta, rather than cfPWV, reflecting stiffness of the whole aorta, is related to LVH in hypertensive individuals [30] . It should also be noted that, while hypertension induces a similar remodeling (enlargement) in both aorta and carotid arteries, as a consequence of elastin fiber fracture induced by increased pulsatile mechanical load, the stiffening effect of hypertension involves mainly the aorta [28] . However, bearing in mind the abovementioned limitations, our data suggest that carotid stiffness is a more adequate proxy of thoracic aorta (which can be studied only by MRI in research settings) than cfPWV for the noninvasive study of the contribution of large artery stiffness to LVH development, even in the clinical setting.
Taken together, our results suggest that aortic and carotid stiffness could not be used interchangeably as predictors of cardiovascular and renal risk in hypertensive patients. This hypothesis is reinforced by the fact that the simultaneous presence of increased cfPWV and increased carotid stiffness is not associated with further worsening of target organ damage.
Association of carotid stiffness and carotidfemoral pulse wave velocity with cardiovascular risk factors
In our hypertensive population, metabolic factors emerged as major determinants of carotid stiffness and cfPWV, and this effect was independent of the classification chosen [6, 16, 31] . Indeed, accumulating evidence support the hypothesis that metabolic factors, such as type 2 diabetes mellitus [6, 16] and metabolic syndrome [32, 33] , contribute to increase cfPWV of hypertensive patients. Interestingly, carotid stiffness (brach) but not carotid stiffness is associated with diabetes, because of the fact that PP amplification is increased with increasing levels of blood glucose [34] .
Prevalence of increased carotid stiffness and carotid-femoral pulse wave velocity according to different cutoffs Finally, our results highlight remarkable differences in prevalence of increased cfPWV and carotid stiffness, as well as in their association with target organ damage, when a fixed cutoff obtained from a local control group or age-specific international reference values are used. This striking discrepancy might be explained by several factors. First, to compare with reference values, carotid stiffness was calculated using brachial PP instead of local PP. Thus, the significant association between LVH and carotid stiffness might be driven by a tighter association of LVH with central BP than with brachial BP [35] . Indeed, the discrepancy is reduced, even though not abolished, when carotid stiffness was calculated using brachial PP and dichotomized using a fixed cutoff from our local healthy population, probably as a consequence of the selective impact of some risk factors, such as diabetes, on PP amplification [34] . Second, genetic and environmental factors such as ethnicity, latitude, outdoor temperature, and lifestyle are established determinants of BP [36, 37] and vascular stiffness [10] . Therefore, the single-center nature of our study might have reduced the bias potentially introduced by the enrollment of patients and controls from diverse geographic areas as in multicentric studies. In line with this possibility, we observed greater discrepancies between the two classifications for carotid stiffness than for cfPWV, possibly indicating a greater impact of geographical and/or genetic factors on the carotid vessel than the aorta. Finally, the use of agespecific reference values might be a more appropriate way for controlling for the effect of aging on arterial stiffness and target organ damage parameters. The use of age and sex-specific cutoffs seems also useful to take into account for the different impact of HR on central and brachial BP [38] , as sex is a crucial determinant of both carotid stiffness and HR. Indeed, in our study, HR remained an independent determinant of carotid stiffness only in the model considering age and sex-specific cutoffs, whereas, when a single cutoff was used for men and women, female sex rather than HR remained an independent determinant.
Limitations
Possible limitations of the present study should be acknowledged. First, the cross-sectional design does not allow drawing any conclusion on a causal relationship of the observed associations. Furthermore, our hypertensive patients, recruited among those performing a target organ damage evaluation in an ESH Excellence Center, might not be representative of the general hypertensive population, as well as the control group, which has been recruited on purpose. Finally, subtracted rather than direct distance was used for cfPWV calculation, while the latter is currently preferred [39] . However, appropriate cutoffs for cfPWV calculated with subtracted distance, provided as Supplemental material by the Reference Values for Arterial Stiffness Collaboration [13] , were used for the present analysis.
Perspectives
Arterial stiffening in hypertension is a systemic process, which seems to proceed differently at the aortic and carotid level in hypertensive patients and leading to different consequences on target organ damage. Thus, despite growing evidence supporting the importance of carotid stiffness evaluation as an independent predictor of cardiovascular events [5, 40] , whether carotid stiffness provides additional or complementary information to cfPWV remains largely undetermined. Our data indicate that aortic and carotid stiffness provide complementary information on target organ damage accrual in hypertensive patients, but its predictive role for organ damage development needs to be assessed in large prospective clinical trials.
Reviewers' Summary Evaluations
Referee 1
This study assesses the differential role of carotid and aortic stiffness in hypertension and the association with endorgan damage. Findings show that carotid stiffness is associated with left ventricular mass and aortic stiffness with renal function. Although the study extends the significance of carotid stiffness and aortic stiffness on the overall risk in hypertensive subjects, the results are obtained by using arbitrary thresholds of the 90th percentile of a local control population and also by employing brachial pulse pressure and carotid diameter, measurement of quantities at different sites, for computation of carotid stiffness.
Referee 2
The paper by Dr Bruno et al. shows the different information given by carotid versus aortic stiffness in target organ alterations. Carotid stiffness seems closely associated with left ventricular mass, while PWV with renal failure. This finding helps to differentiate the role of different arterial segments in the pathophysiology of cardiovascular disease. A major weakness is that the control group was recruited by advertising and individuals were matched for age and gender with the hypertensive population enrolled. Therefore, the control group may not be representative of the local general population.
